-
Published 9/10/2025
Ruberg FL, Teruya S, Helmke S, Smiley DA, Fine D, Kurian D, Raiszadeh F, Prokaeva T, Spencer B, Wong S, Pandey S, Blaner WS, DeLuca A, Johnson LL, Kinkhabwala MP, Leb J, Mintz A, LaValley MP, Einstein AJ, Cohn E, Gallegos C, Murtagh G, Kelly JW, Miller EJ, Maurer MS. Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. 2025 Sep 10. PMID: 40928765.
-
Published 9/1/2025
Pandey S. The case for serial quantitative cardiac amyloid radionuclide imaging - will nuclear cardiology continue to transform care in transthyretin cardiac amyloidosis? J Nucl Cardiol. 2025 Sep; 51:102446. PMID: 40973356.
-
Published 9/12/2024
Hage FG, Bourque JM, Pandey S, Shah NR, Soman P, Abbott BG, Abidov A, Aggarwal NR, AlJaroudi W, Bhambhvani PG, Bokhari S, Dorbala S, Doukky R, Duran JM, Einstein AJ, Gallagher D, Hendel RC, Jaber W, Kattan CG, Malhotra S, Masri A, Miller EJ, Murthy VL, Sperry BW. American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging. J Nucl Cardiol. 2024 Oct; 40:102041. PMID: 40590833.
-
Published 12/1/2023
Chan N, Einstein AJ, Griffin JM, Rosenblum H, Teruya S, Cuomo M, De Los Santos J, DeLuca A, Johnson LL, Kinkhabwala MP, Leb JS, Mintz A, Fine D, Helmke S, Muralidhar V, Pandey S, Sabogal N, Saith SE, Winburn M, Smiley D, Miller EJ, Ruberg FL, Maurer MS. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. J Nucl Cardiol. 2023 Dec; 30(6):2531-2539. PMID: 38245059.
-
Published 6/13/2023
Chan N, Einstein AJ, Griffin JM, Rosenblum H, Teruya S, Cuomo M, De Los Santos J, DeLuca A, Johnson LL, Kinkhabwala MP, Leb JS, Mintz A, Fine D, Helmke S, Muralidhar V, Pandey S, Sabogal N, Saith SE, Winburn M, Smiley D, Miller EJ, Ruberg FL, Maurer MS. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. J Nucl Cardiol. 2023 Dec; 30(6):2531-2539. PMID: 37311914.